Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on July 26, 2002

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet.

PLEASE DO NOT  include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]
 
78N-0038 Sunscreen Drug Products *
87F-0179 Sucrose polyester as replacement for fats & oil in food *
95N-0308 Inapplicability of the Dietary Supplement Health & Ed. Act t *
00F-0792 OLESTRA  REMOVE REQUIREMENT FOR LABEL STATEMENT *
00N-1571 Enrofloxacin for Poultry: Opportunity for hearing *
01M-0342 P980044; SUPARTZ Dispo *
01P-0560 Refrain Approval of Any Buprenorphine Product *
02D-0258 Sudies for Orally Administered Drug Products *
02N-0209 Governing First Amendment Case Law *
02N-0215 Export Certificates *
02P-0138 ANDA for Carisoprodol Orally Disintegrating Tablets, 350mg *

78N-0038 Sunscreen Drug Products

ACK 7 HFA-305 Vol#: 146

PSA 3 C T F A & CHPA Vol#: 146

87F-0179 Sucrose polyester as replacement for fats & oil in food

LET 10 HFS-200 to CSPI Vol#: 34

95N-0308 Inapplicability of the Dietary Supplement Health & Ed. Act t

C 251 Lisa M. Fife Vol#: 11

C 252 Mara Mendez Vol#: 11

C 253 Denise Kobylarz & Kasha Vol#: 11

C 254 Carol Skourtis Vol#: 11

C 255 Louann Cole Vol#: 11

C 256 Leslie Grant Albert, O.D. Vol#: 11

C 257 Eloise D. Morano Vol#: 11

C 258 Mary L. Hackmann Vol#: 11

C 259 Mrs. Barbara Erickson Vol#: 11

C 260 Beverly Dziura Vol#: 11

C 261 Anne E. Daniels-Severs, Ph.D. Vol#: 11

C 262 Pauline Lucia Vol#: 11

C 263 Jodie A. Lee Vol#: 11

C 264 Louis & El Doris Haveriah Vol#: 11

C 265 Barbara Constantine Vol#: 11

C 266 David Wadsworth Vol#: 11

C 267 Gina Randolph Vol#: 11

C 268 Tim & Debra Casey Vol#: 11

C 269 Betty L. Ware Vol#: 11

C 270 Constance E. Sweitzer Vol#: 11

C 271 Connie Stoltz Vol#: 11

C 272 Robin Coblyn Vol#: 11

C 273 Carrie Quatsoe Vol#: 11

C 274 Crystal Burnett Vol#: 11

C 275 Christa Grogan Vol#: 11

C 276 Janine Krystofosky Vol#: 11

C 277 Lyn C. Abissi Vol#: 11

C 278 Mr. & Mrs. Harvin C. Moore Vol#: 11

C 279 Grace J. Knudson Vol#: 11

C 280 Sharon Herrmann Vol#: 11

C 281 Law Office of Amy D. Blackmon Vol#: 11

C 282 Mary F. Mistak Vol#: 11

C 283 Mary Dick Vol#: 11

C 284 Diane Probst Vol#: 12

C 285 Lynne Kronvold Vol#: 12

00F-0792 OLESTRA BE AMENDED REMOVING REQUIREMENT FOR LABEL STATEMENT

LET 2 HFS-200 to CSPI Vol#: 10

00N-1571 Enrofloxacin for Poultry: Opportunity for hearing

RIN 1 Center for Veterinary Medicine Vol#: 259

RMO 8 Center for Veterinary Medicine Vol#: 259

01M-0342 P980044; SUPARTZ Dispo

CR 1 Seikagaku Corporation (Quintiles, Inc.) Vol#: 1

01N-0067 Reclassification of Dental Mercury

C 23 Cal Gandy Vol#: 3

01P-0230 Domestic Marketing & Importation of Transgenic Fish

EMC 1991 Form Letter Count Vol#: 210

EMC 1992 Form Letter Count Vol#: 211

01P-0560 Refrain Approval of Any Buprenorphine Product

C 1 Purdue Pharma, LP Vol#: 1

02D-0258 Sudies for Orally Administered Drug Products

EXT 1 Generic Pharmaceutical Assn Vol#: 1

02N-0152 Obtain Timely Pediatric Studies & Adequate Pediatric Labelin

C 145 Karen D. Fairchild, M.D. Vol#: 4

C 146 Christopher P. Keuker, MD Vol#: 4

C 147 Robert M. Jacobson, MD Vol#: 4

02N-0209 Governing First Amendment Case Law

C 7 Elaine Hein Vol#: 2

C 8 Margaret Gilhooley Vol#: 2

02N-0215 Export Certificates

C 1 Abbott Laboratories Vol#: 1

02N-0329 Protection of Human Subjects in Clinical Trials

NM 1 Vol#: 1

02P-0138 ANDA for Carisoprodol Orally Disintegrating Tablets, 350mg

WDL 1 Lachman Consultant Services, Inc. Vol#: 1

02V-0331 laser light show

ACK 1 HFA-305 Vol#: 1

VAR 1 Vinyl Circus Vol#: 1